Dysregulation of the UBA1 pathway is associated with accumulation of β-catenin, and inhibition of β-catenin signalling by quercetin reverts the UBA1-dependent neuromuscular pathology in zebrafish, Drosophila and mouse models of SMA (Wishart et al., 2014). Here, UBA1 is linked to proximal spinal muscular atrophy.